Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural insights into Arabidopsis thaliana CTS-mediated fatty acid and hormone metabolism.

Nature communications·2026
Same author

Enhanced Polar Auxin Transport and Reduced Brassinosteroid Activity Drive Internode Elongation in Chinese Fir (<i>Cunninghamia lanceolata</i>).

Plants (Basel, Switzerland)·2026
Same author

Correction: A new mechanism of arterial calcification in diabetes: interaction between H3K18 lactylation and CHI3L1.

Clinical science (London, England : 1979)·2026
Same author

Corrigendum to 'Dapagliflozin activates the RAP1B/NRF2/GPX4 signaling and promotes mitochondrial biogenesis to alleviate vascular endothelial ferroptosis' [Cell Signal. 2025 Aug, 132:111824].

Cellular signalling·2026
Same author

Neutrophil-lymphocyte ratio, albumin-alkaline phosphatase ratio, and bilirubin predict outcomes in hepatectomy hepatolithiasis patients.

World journal of gastrointestinal surgery·2026
Same author

Beyond metal-centric catalysis in dual-atom catalysts: bridge N sites drive dehydrogenation <i>via</i> Co-Cu synergy.

Physical chemistry chemical physics : PCCP·2026

Related Experiment Video

Updated: Jun 23, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K

Acute Leukemia Warning Model Combined CBC and CPD Data Based on Machine Learning.

Hong-Wei Gao1, Ying-Ying Wang1, Xiang Li2

  • 1Laboratory Medicine Center, The Second Hospital of Lanzhou University, Lanzhou, China.

International Journal of Laboratory Hematology
|August 6, 2025
PubMed
Summary
This summary is machine-generated.

A new warning model using complete blood count (CBC) and cell population data (CPD) can aid in early acute leukemia (AL) detection. The support vector machine (SVM) model demonstrated high accuracy in identifying AL patients.

Keywords:
CBCCPDSVM modelacute leukemiavalidationwarning model

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

269

Related Experiment Videos

Last Updated: Jun 23, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.6K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.1K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

269

Area of Science:

  • Hematology
  • Medical Informatics
  • Machine Learning in Healthcare

Background:

  • Early diagnosis of acute leukemia (AL) is critical for improving patient survival rates.
  • Complete blood count (CBC) and cell population data (CPD) are valuable for disease detection.
  • Developing effective warning models can assist clinicians in diagnosing AL.

Purpose of the Study:

  • To develop and evaluate a warning model for acute leukemia (AL) detection.
  • To utilize complete blood count (CBC) and cell population data (CPD) for AL screening.
  • To compare the performance of different machine learning models in AL diagnosis.

Main Methods:

  • Retrospective collection of CBC and CPD data from AL and non-AL patients.
  • Development of Support Vector Machine (SVM), Random Forest (RF), and Logistic Regression (LR) models.
  • Validation of the optimal model using independent test and validation datasets.

Main Results:

  • The SVM model demonstrated superior diagnostic accuracy compared to RF and LR models.
  • SVM model achieved high accuracy (92.93% training, 89.66% test) and AUC (0.981 training, 0.959 test).
  • The SVM model showed satisfactory effectiveness and feasibility in external validation (76.34% accuracy, 0.841 AUC).

Conclusions:

  • The Support Vector Machine (SVM) model shows significant potential as a clinical screening tool for acute leukemia (AL).
  • The developed model effectively utilizes CBC and CPD for AL detection.
  • The SVM model's performance supports its feasibility for aiding clinical diagnosis.